[{"id":"22923149-06d3-45f2-a2f9-f7f680b159a8","acronym":"","url":"https://clinicaltrials.gov/study/NCT00794781","created_at":"2021-01-18T03:00:59.393Z","updated_at":"2024-07-02T16:36:02.453Z","phase":"Phase 1","brief_title":"A Phase 1, Multicenter, Open-Label, Dose-Escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of E6201 in Subjects With Advanced Solid Tumors","source_id_and_acronym":"NCT00794781","lead_sponsor":"Eisai Inc.","biomarkers":" BRAF","pipe":"","alterations":" ","tags":["BRAF"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e E6201"],"overall_status":"Completed","enrollment":" Enrollment 55","initiation":"Initiation: 06/22/2008","start_date":" 06/22/2008","primary_txt":" Primary completion: 08/01/2011","primary_completion_date":" 08/01/2011","study_txt":" Completion: 10/15/2015","study_completion_date":" 10/15/2015","last_update_posted":"2022-10-14"}]